PhD in Health Sciences from the
Medical University of the Americas
Dr. Neil Riordan
CEO
Founded Signature Biologics in 2018 with more than 30 years of experience in applied stem cell research.
One of the earliest pioneer and expert in applied stem cell research and founder of 5 intercontinental companies that specialize in various biomedical products ranging from the use of adult stem cells in Panama to human umbilical cord tissue products produced in the US.
Dr. Jonathan Hernandez
VP of Research & Development
PhD in Human Physiology and Regenerative Biology from the
University of Wisconsin-Madison
Joined Signature Biologics in 2018 and is responsible of the department of Research and Development.
Over 10 years of experience in the field of regenerative biology, cardiovascular research and translational medicine. Skilled in Stem Cell Biology, Human Induced Pluripotent Stem Cells (hiPSCs), Mesenchymal Stem Cells derived from umbilical cord (UC-MSCs) and Cardiac electrophysiology. Well experienced overseeing R&D and clinical product manufacturing operations in compliance with set regulations and policies.
Angelica Rivas
Laboratory Director
BS in Biotechnology from Universidad San Martin de Panama; MBA in Project Management Universidad Latina de Panama
Joined Signature Biologics in 2018 and is responsible for laboratory manufacturing operations and compliance with applicable regulations and standards.
Over 10 years in the regenerative medicine industry using adult stem cells starting in MediStem Panama, working in the Production Department as a Laboratory Technician and Cell Line Coordinator. Well experienced in implementation of Quality Management System (QMS) after 6 years in MediStem Panama in the role of Quality Assurance.
JIll Baker
Director of Human Resources
Masters of Education
from Columbia University
Joined Signature Biologics in 2019 and is responsible for HR leadership and administration, various operational projects, and executive team support.
Over 17 years of experience in HR, consulting and operations. Prior to current role, worked with individual financial advisors to build enterprise value through practice management structures and the development of multigenerational enterprise teams. Held leadership positions in multiple industries; including non-profit, as Executive Director of PlaySmart, in education, as Collaboration Coordinator for Economic Opportunity at the Skandarlaris Center for Entrepreneurial Studies at Washington University in Saint Louis, and in various corporations.
Neal Wright
Business Systems Director
BS in Kinesiology from Arizona State University
Joined Signature Biologics in 2018 and is responsible for managing IT/business systems’ growth, network operations, and facilities operations coordination.
Over 10 years of experience in small business environments, managing operations to improve efficiencies and automate processes. Particularly versed in problem solving, conceptualization, and end-to-end project execution with an emphasis on information technologies.
Greg Salcido
VP of Finance & Accounting
Masters in Professional Accounting and a BBA from the University of Texas at Austin
Joined Signature Biologics in 2021 and is responsible for Financial Leadership, including financial and capital management strategies, budgeting and planning, accounting, audit, tax, and treasury.
Over 25 years of diverse financial leadership experience with companies ranging from startups to established, multi-national corporations.He has held senior finance leadership positions with both manufacturing and high growth startup companies.Most recently, Greg spearheaded a successful management consulting business that catered to small, high-growth businesses before joining the Signature Biologics Managing Directors team.
Dr. Ramon Coronado
VP of Regulatory Affairs and Technology Transfer
Technology Entrepreneurship and Management Graduate Certificate at UTSA; M.S and Ph.D. Biomedical Engineering at UT San Antonio/ UT Health San Antonio
Joined Signature Biologics in 2021 and is responsible for Technology Transfer, which includes involvement in all steps pertinent to clinical translation, from scientific discovery to clinical translation and regulatory approval.
Over 10 years of experience in cellular and regenerative medicine research and extensive experience in start-up companies focused on biomedical technologies. Dr. Coronado has filed multiple patent applications in biotech and has founded several biomedical companies in an effort to challenge the status quo of medicine by bringing better medical solutions to patients.
